Monthly Archives: February 2019

A randomized, open label, comparative, five-arm, controlled study evaluating the benefit and tolerability of oral superoxide dismutase combined with gliadin as add-on neutraceutical therapy with standard therapy in Indian patients with melasma

Vedamurthy M et al. Int J Res Dermatol. 2018 Nov;4(4):471-478

Maya Vedamurthy, Philippe Humbert

“Benefits of SOD-gliadin supplementation in the treatment of melasma”

RSV Skin and Laser Centre, Chennai, Tamil Nadu, India
Department of Dermatology, University Hospital, Head of Laboratory of Cutaneous Engineering and Biology, University Hospital, France

                                                (Click on the title of the study above for link to full document.)